Stents were delivered in a (1) percutaneous, (2) intraoperative, or (3) hybrid fashion, with operative exposure expressly for the purpose of transcardiac access (Figure 1 ).
I n patients with congenital heart disease, stenting of the left ventricular outflow tract (LVOT) and creation or enlargement of a ventricular septal defect (VSD) using a stent may be a therapeutic option in rare clinical situations. 1, 2 Stent fracture is a well-recognized complication in several clinical scenarios, most notably when stents are placed near pulsatile or dynamic structures such as the heart or proximal great vessels. [2] [3] [4] [5] [6] [7] [8] In fact, evidence suggests that when excessive external loading forces are applied to stents, either from dynamic compression or other cyclic stresses, the risk for stent fracture is higher. 6, 7, 9 As more stent-based applications are introduced to clinical practice, it will be important to better understand the midterm to long-term fate of stents placed inside the heart, where they may be especially exposed to cyclic compressive, flexional, and torsional stresses. This study reviews our experience with bare-metal stents placed in the ventricular septum or LVOT, with special attention paid to efficacy of the procedure and the incidence of adverse events, including stent fracture, as well as to the clinical indicators of midterm to long-term functional integrity of these stents.
Hemodynamic and Functional Evaluation
Hemodynamic data were obtained from echocardiograms and catheterization reports. All available angiograms were reviewed. Gradients obtained by catheterization were peak-to-peak gradients. In some patients who underwent intraoperative stenting, pressures were directly measured, and a peak-to-peak gradient was reported. Data obtained from the echocardiograms included the qualitative degree of regurgitation of the semilunar and atrioventricular valves and the Doppler-derived maximum instantaneous gradient across the area of obstruction.
Stent Fracture
Patients who underwent follow-up chest fluoroscopy and angiography ( Figure 2 ) or repeat surgery were assessed for stent fractures. Chest radiography was not considered sufficient to exclude the diagnosis.
In-Stent Stenosis
Angiographically, the in-stent stenosis was quantified by measuring the diameter of the stent (A) and the minimal diameter of the column of contrast within the stent (B), and these measurements were used to calculate the percent diameter stenosis [(A-B)/A].
Data Analysis
The outcomes were survival free from diagnosis of stent fracture, survival free from any reintervention for recurrent outflow obstruction, survival free from surgical reintervention for recurrent outflow obstruction, survival free from stent fracture or reintervention, and short-term changes in hemodynamic variables. For comparison between preintervention and postintervention data, the Wilcoxon signed rank test was used. For comparison of independent outcome groups, the Wilcoxon rank sum test was used. Time-to-event outcomes were evaluated using Kaplan-Meier analysis. Cox regression analysis was used to evaluate predictors of shorter freedom from a diagnosis of stent fracture. Although stent fracture should be considered a time-dependent outcome, it was generally not clinically evident and depended on assessment with fluoroscopy or surgery, so this evaluation was performed as an analysis of freedom from the diagnosis of stent fracture and as a time-independent categorical outcome (fracture versus no fracture). Patients without a diagnosed stent fracture were censored event free at the time of the most recent radiographic, echocardiographic, or surgical evaluation. For analysis of freedom from diagnosis of a stent fracture, patients who underwent reintervention but did not have a stent fracture before reintervention and
WHAT IS KNOWN
• Stent fracture is a well-recognized complication, particularly when stents are placed near pulsatile or dynamic structures.
• It is important to better understand the midterm to long-term fate of stents placed inside the heart, where they are exposed to cyclic compressive, flexional, and torsional stresses.
WHAT THE STUDY ADDS
• In patients with obstruction of the left ventricular outflow tract after surgery for congenital heart disease or those with a functionally isolated ventricle at high pressure, transcatheter, intraoperative, or hybrid stenting of the ventricular septum or left ventricular outflow tract is feasible.
• These procedures reduce the gradient across the obstruction and the pressure in the hypertensive ventricle.
• However, the incidence of significant reobstruction was high, and more than one half of the patients in the series underwent reintervention during the follow-up period.
• There is a high incidence of stent fracture. had the stent left in situ were not censored at the time of reintervention; if the unfractured stent was removed, however, the patient was censored event free at that time. Data are presented as mean±SD, median (minimum-maximum), or frequency (%).
Results

Patients
Twenty-seven patients underwent placement of ≥1 baremetal stent in the ventricular septum or LVOT ( Table 1) .
The median age at the time of stent placement was 4.6 years (6 days-47 years). We classified patients into 3 groups based on the site of and physiological indication for stent placement (Figure 3 ).
Group 1 comprised patients with LVOT obstruction in a biventricular circulation (n=8). In 6 of these patients, the LVOT consisted of a native or surgically enlarged conoventricular VSD through which the left ventricle was baffled with a patch to the aorta. In the other 2 patients, the native LVOT was obstructed (patients 1 and 8). Group 2 comprised patients with functional univentricular physiology and LVOT obstruction through a native VSD (n=15). In 9 of these patients, the left ventricle was the secondary ventricle, with its main outlet being the restrictive VSD. In the other 6 patients, the left ventricle was the principal ventricle, with the VSD serving as the main outlet to the systemic circulation. Group 3 comprised patients with a functionally isolated left ventricle (n=4), with near atresia or atresia of the aortic valve without a VSD. Six patients (22%) had undergone previous attempts to decompress the ventricle (3 surgical enlargements of VSD, 1 balloon dilation of apical VSD, and 2 balloon dilations of the aortic valve).
Procedures
Eighteen patients underwent stent placement using a percutaneous approach (6 in group 1 and 13 in group 2), 8 patients underwent intraoperative stent placement (2 in group 1, 2 in group 2, and all 4 in group 3), and 1 underwent hybrid stent placement in the catheterization laboratory (patient 2). Seven of the patients who underwent VSD creation or enlargement using the percutaneous approach were included in a prior report. 10 The percutaneous approach for VSD creation or enlargement was previously described. 10 Test balloon inflation (looking for stretch-induced heart block before stent implantation) was performed in all cases of percutaneous stenting except 1 (patient 17).
Intraoperative stent placement was performed under direct visualization during open heart surgery. A guidewire was passed across the ventricular septum either through a VSD or through a newly created defect in the septum (using surgical instruments or a needle). A balloon catheter with a premounted stent was then passed over the guidewire so that the stent straddled the septum, and the balloon was inflated to deploy the stent. Some stents were trimmed or flared using surgical instruments with the goal of improving stability and avoiding interference with intracardiac structures.
A hybrid approach was used in 1 patient with multiple comorbidities (patient 2) in an attempt to avoid cardiopulmonary bypass. A previous attempt at percutaneous residual patch margin VSD occlusion and LVOT stent placement had failed. The procedure was performed in the catheterization laboratory through a left anterior thoracotomy and using transapical access to the left ventricular cavity ( Figure 1) .
The types and numbers of stents are listed in Table 1 . All but 4 patients received a single stent, and premounted stents were used in 10 patients (37%). 
Acute Outcomes
The procedure was successful in reducing the pressure in the hypertensive ventricle as summarized in Table 2 .
Acute and Procedural Adverse Events
Six patients had procedural or acute adverse events. One had balloon rupture, with a balloon fragment retained in the femoral vein that required surgical removal (patient 20). One had acute embolization of a stent to the aortic arch (patient 16). Two developed permanent complete heart block during the procedure (patients 5 and 21). Two had an acute increase in the degree of systemic atrioventricular valve regurgitation after stent placement wherein patient 16 had severe tricuspid regurgitation, and the stent was in contact with the tricuspid valve (no intervention was performed) and patient 23 had severe mitral regurgitation requiring surgical repair of a tear in the anterior mitral valve leaflet 1 week after stent implantation.
Follow-Up
The median duration of follow-up from stent placement until exit from the study (stent removal or transplant), death, or last clinical follow-up was 2.8 years (6 days-13.4 years).
Eleven patients exited the study at a median of 2.4 years (0.6-9.5 years) (10 stent removals and 1 transplant). There were 5 deaths in the cohort (2 after the patients had exited the study) a median of 0.4 years (6 days-14.0 years) after stent implantation.
Recurrent Obstruction of the Stented Ventricular Outflow
Sixteen of the 27 patients (59%) developed significant reobstruction of the stented ventricular outflow (mean maximum instantaneous gradient, 60±33 mm Hg). Three mechanisms of reobstruction were encountered ( Figure 4 ) as follows: (1) stent fracture, (2) in-stent stenosis, and (3) incomplete coverage of the obstructive tissue by the stent. All patients with reobstruction in whom angiograms or operative notes were available for review (15 of 16) had evidence of in-stent stenosis. Three of the 16 patients (19%) had in-stent stenosis as the only identifiable mechanism of obstruction. Two patients had complete occlusion of the stent. In the 10 patients with in-stent stenosis and available angiograms, the median percent diameter stenosis was 29% (22%-100%). The median absolute difference between the diameter of the stent and the minimal diameter of the column of contrast within the stent (excluding patients with complete occlusion) was 3 mm (1.5-4.6 mm). Eleven of the 16 patients (69%) with reobstruction had a stent fracture. Among patients with reobstruction, there was no significant difference in the gradient between those with and without stent fracture (63 [40-119] and 60 mm Hg, respectively, P=0.5). In 2 patients (12%), the obstruction was partly due to incomplete coverage of the obstruction by the stent.
Reinterventions
Sixteen of 27 patients (59%) underwent reintervention of the stented ventricular outflow (15 for reobstruction and 1 to place a larger stent during a scheduled surgery). Survival free from reintervention was 75% at 1 year and 43% at 3 years ( Figure 5 ). Twelve patients underwent redilation of the stent with (n=6) or without (n=6) placement of new stents as an initial reintervention. In 7 of these patients, the initial stent was fractured, and in 1, it was completely occluded (patient 14). Five patients underwent surgery as the first reintervention. Of the 12 patients who initially underwent percutaneous reintervention, 7 subsequently had surgical stent removal and enlargement of the stented outflow tract. A total of 11 patients underwent surgical relief of LVOT obstruction after initial stent placement. There were no reported complications specifically related to removal of the stent at the time of reoperation. Survival free from surgical reintervention was 92% at 1 year and 66% at 3 years ( Figure 5 ). Reinterventions in general were successful in decreasing the gradient across the ventricular outflow (Table 3 ). However, the reduction in gradient was not statistically significant in the patients who underwent balloon dilation only of the stented LVOT (without restenting) (P=0.06). None of these patients had a reduction of the gradient <25 mm Hg, whereas all patients who underwent restenting had a gradient ≤25 mm Hg after the reintervention.
Stent Fracture
Stent fracture was diagnosed in 11 patients (41%) a median of 2.6 years (10 days-7.8 years) after placement. All the stent fractures were associated with significant reobstruction (maximum instantaneous gradient, ≥50 mm Hg). Three of the 8 patients in group 1 (38%), 7 of the 15 in group 2 (47%), and 1 of the 4 in group 3 (25%) were found to have a stent fracture. There was 1 case of stent fragment embolization (patient 1), which occurred during recatheterization 6 months after stent placement. While crossing the fractured stent, a fragment embolized to the descending thoracic aorta. The patient underwent surgery to excise the remainder of the stent, reconstruct the LVOT, and remove the embolized fragment.
Overall, survival free from a diagnosis of stent fracture was 84% at 1 year and 73% at 3 years ( Figure 5 ). Survival free from the diagnosis of stent fracture or reintervention was 71% at 1 year and 44% at 3 years. Among 7 patients who had a second stent placed at a subsequent catheterization (5 for a *Reported gradients were directly measured peak-to-peak gradients. fractured initial stent), 1 was later found to have a fracture of the second stent. None of the variables analyzed (stent type, group, flaring of the stent edges during intraoperative placement, intraoperative placement of the stent, age at time of stent placement, and location of stent placement) were associated with the diagnosis of stent fracture or shorter survival free from the diagnosis of stent fracture.
Ventricular Aneurysms
One patient had a ventricular aneurysm (patient 22), which was present at the time of the original stent placement and did not continue to grow after the procedure. Placement of stents across the ventricular septum did not result in septal aneurysm formation in any patient.
Adverse Events During Follow-Up
Two patients developed progressive regurgitation during follow-up. Patient 2 had progressive mitral regurgitation from trivial before stent placement, to mild immediately after, to moderate within 1 year. Transesophageal echocardiography showed that the stent was in contact with the anterior mitral valve leaflet, which was flail and prolapsed ( Figure 6 ). This patient underwent mitral valve replacement 16 months after stent placement. Patient 6 had aortic regurgitation that increased from mild to moderate 7 years after stent implantation in the setting of progressive dilation of the aortic root.
Follow-Up Hemodynamics
Among the 8 patients who did not undergo reintervention for recurrent obstruction and had a follow-up of at least 3 months after stent placement (2 in group 1, 4 in group 2, and 2 in group 3), the median gradient obtained by echocardiogram was 0 mm Hg (0-20 mm Hg) at a median follow-up of 1.3 years (0.3-7.9 years). Three of these patients also had repeat catheterizations at least 1 year after the initial stent placement, with measured peak-to-peak gradients between 0 and 10 mm Hg. The median duration between stent implantation and the last echocardiogram for the entire cohort was 4 years (2 days-11.6 years). The median maximum instantaneous gradient at the latest follow-up echocardiogram was 16 mm Hg (0-100 mm Hg).
Discussion
In patients with obstruction of the LVOT after surgery for congenital heart disease or in those with a functionally isolated ventricle at high pressure, transcatheter, intraoperative, or hybrid stenting of the ventricular septum or LVOT is feasible. To our knowledge, this is the first report of intraoperative placement of stents to create or enlarge a VSD or to enlarge a reconstructed LVOT.
In this study, we demonstrate that these procedures are successful in reducing for the short term the gradient across the obstruction and in reducing the pressure in the hypertensive ventricle. Surgical reintervention was avoided, or at least delayed by >1 year, in the majority of the patients in the series. Of the patients who underwent surgical reintervention, the average duration from the time of stent placement was 3 years. However, more than one half of the patients in the series underwent reintervention during the follow-up period, and surgery was eventually performed in many.
The procedure was performed safely and without complications in the majority of the patients in the series. However, there were significant procedural or stent-related complications in some cases. There was significant interference with atrioventricular valve function in 3 patients (leading to surgical intervention in 2). Two patients developed permanent complete heart block (neither with L-looped ventricles). It is worth noting that in the patient who developed complete heart block after percutaneous placement of an LVOT stent, test balloon dilation was performed before deployment of the stent, yet complete heart block only resulted after stent placement. Ventricular or septal aneurysms did not occur after stent placement in this cohort.
Even though the stents were in proximity to the aortic or neoaortic valve in the majority of the patients, only 1 patient in the series had an increase in the degree of semilunar valve regurgitation on long-term follow-up. The stent did not interfere directly with valve function, but it is conceivable that the direction of the flow jet through the stent into the LVOT directly affected the aortic valve leaflets or contributed to dilation of the aortic root.
Nearly 60% of the patients in the cohort developed significant reobstruction. The 3 mechanisms of obstruction were fracture, in-stent stenosis, and incomplete coverage of the obstructive tissue. These mechanisms likely explain the limited response observed in patients who underwent balloon dilation alone as a reintervention compared with those who underwent restenting.
Fracture is a well-known complication after placement of balloon-expandable stents. [3] [4] [5] [6] [7] [8] [9] [11] [12] [13] It has been reported to occur in up to 43% of patients after bare-metal stent placement in right ventricular-to-pulmonary artery conduits, 7 in up to 26% of patients after Melody valve placement, 6, 8 and in 21% of stents placed in the central pulmonary arteries. 14 In the present series, 41% of patients were found to have stent fractures on follow-up, and survival free from the diagnosis of stent fracture was 73% at 3 years. Several studies have found that factors that result in higher cyclic compressive stresses on the stent are associated with increased risk of fracture. 6, 7, 9 Perhaps most relevant to the present study, Nordmeyer et al 6 found that implantation of the Melody valve in the native right ventricular outflow tract was one of the risk factors for stent fracture. In the present study, we did not find any risk factors for stent fracture, although we were limited by a relatively small number of patients. Therefore, it is difficult to make recommendations that would help to decrease the incidence of stent fracture in this patient population. Although we did not find the type of stent used to be a risk factor for fracture, more robust stents, such as the Palmaz P10 stents (Johnson & Johnson-Cordis Corporation), were only used in 2 patients in this series. Given the high frequency of stent fracture among patients undergoing this procedure, more robust stents, or possibly multiple concentric stents, should be favored when technically feasible.
In the present study, all stent fractures were associated with significant reobstruction. Although some patients with reobstruction did not have a stent fracture, the presence of significant reobstruction on echocardiogram should raise suspicion for a fractured stent. Fluoroscopy is essential for the diagnosis of stent fracture not only because angles can be optimized and resolution is better than static radiography, but also because the stent motion can be evaluated. Independent motion of different portions of the stent is characteristic of fractures in this setting (online-only Data Supplement Video).
Subaortic stenosis after biventricular repair of a doubleoutlet right ventricle or transposition of the great arteries with VSD has been reported in 3.5% to 11% of cases, and it tends to progress over time. [15] [16] [17] [18] Surgical management of this kind of postoperative obstruction has had mixed results, with some patients experiencing incomplete relief of the obstruction and reoperation rates of up to 27%. 15, 19, 20 Reported complications from these procedures have included complete heart block and damage to the aortic valve. In the present series, patients with obstruction of the LVOT were initially managed with percutaneous placement of stents instead of surgical reconstruction in an effort to avoid reoperation. The short-term results of the procedure were comparable with those of surgery. However, on midterm to long-term follow-up, the incidence of reoperation was higher in the present series. Despite this limitation, this procedure may be useful in certain circumstances, such as in patients who are considered to be at high surgical risk, with the objective of acutely relieving the obstruction, thereby improving the candidacy of the patient for surgery or delaying the operation until the patient needs to have surgery for other reasons (eg, conduit revision, next step in palliation). It is also important to note that there were no surgical complications specifically associated with stent removal. Although our general impression is that stent removal does not unduly prolong the operation, it can add to the complexity of the procedure in some cases, and this should also be taken into account when weighing the risks and benefits of this approach.
One limitation of this study was that the diagnosis of stent fracture depended on evaluation by fluoroscopy, catheterization, or surgery. All stent fractures were associated with recurrent obstruction but were otherwise clinically silent. Thus, the incidence of fractures may be underestimated or the duration of freedom from fracture overestimated. Additionally, various adverse outcomes in this cohort (eg, death, stent removal for reasons other than obstruction, reintervention) are competing risks. Given the small number of patients and events, we did not perform a competing risk analysis. Finally, because of the retrospective nature of this study, there were no preestablished criteria for diagnosing or evaluating for stent fractures or recurrent outflow tract obstruction during follow-up. Therefore, the indications for repeat intervention may not have been uniform across the cohort.
In summary, transcatheter, intraoperative, or hybrid stenting of the ventricular septum or LVOT is feasible and successful in the short term. On midterm follow-up, many patients underwent reintervention or reoperation, and there was a high incidence of stent fracture and reobstruction. Although the procedure can be performed safely in the majority of patients, it may be associated with important complications, like complete heart block or atrioventricular valve regurgitation. Despite these limitations, in some circumstances, the procedure may be useful in reducing the degree of obstruction and the ventricular pressure as well as in avoiding, or at least delaying, the need for surgery.
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